| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Michael Eyre, Michael Absoud, Omar Abdel-Mannan, Sarah Crichton, Yael Hacohen, Thomas Rossor, Sarah Rudebeck, Gavin Giovannoni, Ming Lim, Cheryl Hemingwa. Academic outcomes before and after clinical onset of acquired demyelinating syndromes in children: a matched cohort data linkage study. Annals of clinical and translational neurology. 2024-10-03. PMID:39359055. |
we conducted a matched cohort study using prospectively collected educational data in multiple sclerosis (ms) and myelin oligodendrocyte glycoprotein antibody disease (mogad) patients (n = 60) and controls (pooled n = 449,553). |
2024-10-03 |
2024-10-05 |
Not clear |
| T J Hartung, F Bartels, J Kuchling, S Krohn, J Leidel, M Mantwill, K Wurdack, S Yogeshwar, M Scheel, C Fink. MRI findings in autoimmune encephalitis. Revue neurologique. 2024-10-02. PMID:39358087. |
in some nmda receptor encephalitis cases, these t2-hyperintense lesions may be indicative of an nmda receptor encephalitis overlap syndrome with simultaneous co-existence of multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd) or myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2024-10-02 |
2024-10-05 |
Not clear |
| Jagannadha Avasarala, Christopher McLouth, Abusamra Khawla, Paul Wilkerson, Ellen Anderson-Benge, Karen B Lundgren, Saurav Da. Preliminary findings of a 'test bundle' to accelerate the diagnosis of MS and NMOSD following optic neuritis. Multiple sclerosis and related disorders. vol 91. 2024-09-26. PMID:39326210. |
no study has investigated the length of time it takes to diagnose multiple sclerosis (ms) or neuromyelitis optic spectrum disorder (nmosd, aquaporin 4 antibody disease or myelin oligodendrocyte glycoprotein antibody disease, mogad) following the onset of de novo optic neuritis (on). |
2024-09-26 |
2024-09-29 |
Not clear |
| Paola Perini, Marta Gaggiola, Francesca Rinaldi, Paolo Gallo, Marco Puthenparampi. Relapsing tumefactive demyelination lesions: A unique, distinct inflammatory brain pathology. Multiple sclerosis (Houndmills, Basingstoke, England). 2024-09-09. PMID:39245942. |
our case supports the view that recurrent tdl is a relapsing brain inflammation not belonging to multiple sclerosis (ms) or myelin oligodendrocyte glycoprotein (mog)-/aqp4-associated disorders. |
2024-09-09 |
2024-09-11 |
Not clear |
| Giulia Fadda, Brenda Banwell, Colm Elliott, Dumitru Fetco, Douglas L Arnold, Patrick Waters, E Ann Yeh, Ruth Ann Marrie, Amit Bar-Or, Sridar Narayana. Slowly Expanding Lesions Differentiate Pediatric Multiple Sclerosis from Myelin Oligodendrocyte Glycoprotein Antibody Disease. Annals of neurology. 2024-09-07. PMID:39243229. |
slowly expanding lesions differentiate pediatric multiple sclerosis from myelin oligodendrocyte glycoprotein antibody disease. |
2024-09-07 |
2024-09-10 |
human |
| Li-Tal Pratt, Hadas Meirson, Mika Shapira Rootman, Liat Ben-Sira, Shelly I Shira. Radiological features in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease-diagnostic criteria and lesion dynamics. Pediatric radiology. 2024-09-07. PMID:39243314. |
the spectrum of acquired pediatric demyelinating syndromes has been expanding over the past few years, to include myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), as a distinct neuroimmune entity, in addition to pediatric-onset multiple sclerosis (poms) and aquaporin 4-igg-seropositive neuromyelitis optica spectrum disorder (aqp4+nmosd). |
2024-09-07 |
2024-09-10 |
Not clear |
| Chen Chen, Yaqing Shu, Chengkai Yan, Huilu Li, Zhenchao Huang, ShiShi Shen, Chunxin Liu, Yanjun Jiang, Shixiong Huang, Zhanhang Wang, Feng Mei, Feng Qin, Xiaodong Liu, Wei Qi. Astrocyte-derived clusterin disrupts glial physiology to obstruct remyelination in mouse models of demyelinating diseases. Nature communications. vol 15. issue 1. 2024-09-06. PMID:39242637. |
multiple sclerosis (ms) is a debilitating demyelinating disease characterized by remyelination failure attributed to inadequate oligodendrocyte precursor cells (opcs) differentiation and aberrant astrogliosis. |
2024-09-06 |
2024-09-10 |
mouse |
| Z Smith, V T Cheli, C G Angeliu, C Wang, G E Denaroso, S G Tumuluri, J Corral, K Garbarini, P M Pae. Ferritin loss in astrocytes reduces spinal cord oxidative stress and demyelination in the experimental autoimmune encephalomyelitis (EAE) model. Glia. 2024-09-04. PMID:39228110. |
demyelinating diseases such as multiple sclerosis (ms) cause myelin degradation and oligodendrocyte death, resulting in the release of toxic iron and iron-induced oxidative stress. |
2024-09-04 |
2024-09-06 |
mouse |
| Giulio Volpe, Neringa Jurkute, Gabriela Girafa, Hanna G Zimmermann, Seyedamirhosein Motamedi, Charlotte Bereuter, Lekha Pandit, Anitha D'Cunha, Michael R Yeaman, Terry J Smith, Lawrence J Cook, Alexander U Brandt, Friedemann Paul, Axel Petzold, Frederike C Oerte. Diagnostic Value of Inter-Eye Difference Metrics on OCT for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 6. 2024-09-04. PMID:39231384. |
the diagnostic value of intereye difference (ied) metrics is high for on in patients with multiple sclerosis and aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders, but unknown in myelin oligodendrocyte glycoprotein antibody-associated on (mog-on). |
2024-09-04 |
2024-09-08 |
Not clear |
| Ruth Geraldes, Georgina Arrambide, Brenda Banwell, Àlex Rovira, Rosa Cortese, Hans Lassmann, Silvia Messina, Mara Assunta Rocca, Patrick Waters, Declan Chard, Claudio Gasperini, Yael Hacohen, Romina Mariano, Friedemann Paul, Gabriele C DeLuca, Christian Enzinger, Ludwig Kappos, M Isabel Leite, Jaume Sastre-Garriga, Tarek Yousry, Olga Ciccarelli, Massimo Filippi, Frederik Barkhof, Jacqueline Palac. The influence of MOGAD on diagnosis of multiple sclerosis using MRI. Nature reviews. Neurology. 2024-09-03. PMID:39227463. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is an immune-mediated demyelinating disease that is challenging to differentiate from multiple sclerosis (ms), as the clinical phenotypes overlap, and people with mogad can fulfil the current mri-based diagnostic criteria for ms. |
2024-09-03 |
2024-09-06 |
Not clear |
| Tarun Sharma, Sidharth Mehan, Aarti Tiwari, Zuber Khan, Ghanshyam Das Gupta, Acharan S Narul. Targeting Oligodendrocyte Dynamics and Remyelination: Emerging Therapies and Personalized Approaches in Multiple Sclerosis Management. Current neurovascular research. 2024-09-02. PMID:39219420. |
targeting oligodendrocyte dynamics and remyelination: emerging therapies and personalized approaches in multiple sclerosis management. |
2024-09-02 |
2024-09-04 |
Not clear |
| Amber R Philp, Carolina R Reyes, Josselyne Mansilla, Amar Sharma, Chao Zhao, Carlos Valenzuela-Krugmann, Khalil S Rawji, Ginez A Gonzalez Martinez, Penelope Dimas, Bryan Hinrichsen, César Ulloa-Leal, Amie K Waller, Diana M Bessa de Sousa, Maite A Castro, Ludwig Aigner, Pamela Ehrenfeld, Maria Elena Silva, Ilias Kazanis, Cedric Ghevaert, Robin J M Franklin, Francisco J River. Circulating platelets modulate oligodendrocyte progenitor cell differentiation during remyelination. eLife. vol 12. 2024-08-20. PMID:39163103. |
revealing unknown cues that regulate oligodendrocyte progenitor cell (opc) function in remyelination is important to optimise the development of regenerative therapies for multiple sclerosis (ms). |
2024-08-20 |
2024-08-22 |
mouse |
| Sarah Ingrid Pinto Santos, Santiago José Ortiz-Peñuela, Alessandro de Paula Filho, Ana Laura Midori Rossi Tomiyama, Lilian de Oliveira Coser, Juliano Coelho da Silveira, Daniele Dos Santos Martins, Adriano Polican Ciena, Alexandre Leite Rodrigues de Oliveira, Carlos Eduardo Ambrósi. Oligodendrocyte precursor cell-derived exosomes combined with cell therapy promote clinical recovery by immunomodulation and gliosis attenuation. Frontiers in cellular neuroscience. vol 18. 2024-08-07. PMID:39109218. |
this study aimed to evaluate the therapeutic efficacy of the combination of nscs and evs derived from oligodendrocyte precursor cells (opcs) in an animal model of multiple sclerosis. |
2024-08-07 |
2024-08-09 |
mouse |
| Giuseppe Schirò, Salvatore Iacono, Giuseppe Salemi, Paolo Ragones. The pharmacological management of myelin oligodendrocyte glycoprotein-immunoglobulin G associated disease (MOGAD): an update of the literature. Expert review of neurotherapeutics. 2024-08-07. PMID:39110029. |
myelin oligodendrocyte glycoprotein-immunoglobulin g associated disease (mogad) is a clinical entity distinct from multiple sclerosis and aquaporin-4 (aqp4+)-igg-positive neuromyelitis optica spectrum disorder. |
2024-08-07 |
2024-08-09 |
Not clear |
| Étienne Bénard-Séguin, Christopher Nielsen, Abdullah Sarhan, Abdullah Al-Ani, Antoine Sylvestre-Bouchard, Derek M Waldner, Lindsey B De Lott, Suresh Subramaniam, Fiona Costell. The Role of Artificial Intelligence in Predicting Optic Neuritis Subtypes From Ocular Fundus Photographs. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-08-01. PMID:39088711. |
notably, on associated with multiple sclerosis (ms on) has a good prognosis for recovery irrespective of treatment, whereas on associated with other conditions including neuromyelitis optica spectrum disorders or myelin oligodendrocyte glycoprotein antibody-associated disease is often associated with less favorable outcomes. |
2024-08-01 |
2024-08-05 |
Not clear |
| Meng-Meng Wang, Tao Huang, Jia-Xun Li, Yang Yao, Ying Chen, Kai-Kai Fu, Wen-Rong Miao, Yi Ha. Optic Neuritis Leading to Vision Loss: A Case of MOG-Associated Disease with Successful Immunotherapy. The American journal of case reports. vol 25. 2024-07-26. PMID:39054886. |
background myelin oligodendrocyte glycoprotein (mog)-associated disease (mogad) is a recently described inflammatory demyelinating disease of the central nervous system (cns), which needs to be distinguished from aquaporin-4 (aqp4)-igg-positive neuromyelitis optica spectrum disorder (aqp4-igg+nmosd) and multiple sclerosis (ms). |
2024-07-26 |
2024-07-28 |
Not clear |
| Mary Karalius, Sonam Mohan, Danelvis Paredes, Nailyn Rasool, Riley Bov. Pearls & Oy-sters: Optic Neuritis as First Demyelinating Event During Pregnancy in 2 Young Hispanic Women: MS vs MOGAD. Neurology. vol 103. issue 4. 2024-07-25. PMID:39052965. |
optic neuritis (on) can present as the first demyelinating attack in both multiple sclerosis (ms) and myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad), which may require different treatment depending on the final diagnosis. |
2024-07-25 |
2024-07-28 |
Not clear |
| Yin Yin Tan, Seyed Ehsan Saffari, Janis Siew Noi Tye, Xuejuan Peng, Min Jie Koh, Abu Bakar Shakran Bin Mahmood, Jeanne May May Tan, Kevin Tan, Tianrong Ye. The burden of psychiatric morbidity in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD before and after neurological diagnosis. Multiple sclerosis and related disorders. vol 89. 2024-07-25. PMID:39053396. |
psychiatric comorbidities are common in multiple sclerosis (ms) and are increasingly recognised in aquaporin-4-antibody neuromyelitis optica spectrum disorders (aqp4-ab nmosd) and myelin oligodendrocyte glycoprotein-antibody associated disease (mogad). |
2024-07-25 |
2024-07-28 |
Not clear |
| Yonglin Gao, Lukasz P Slomnicki, Ewa Kilanczyk, Michael D Forston, Maciej Pietrzak, Eric C Rouchka, Russell M Howard, Scott R Whittemore, Michal Hetma. Reduced Expression of Oligodendrocyte Linage-Enriched Transcripts During the Endoplasmic Reticulum Stress/Integrated Stress Response. ASN neuro. vol 16. issue 1. 2024-07-18. PMID:39024571. |
endoplasmic reticulum (er) stress in oligodendrocyte (ol) linage cells contributes to several cns pathologies including traumatic spinal cord injury (sci) and multiple sclerosis. |
2024-07-18 |
2024-07-21 |
rat |
| Sara Samadzadeh, Rafl Adnan, Paulina Berglova, Mahdi Barzegar, Birgit Debrabant, Stine Gundtoft Roikjaer, Michael Levy, Axel Petzold, Jacqueline Palace, Eoin P Flanagan, Sara Mariotto, Soeren T Skou, Anne Froelich, Itay Lotan, Silvia Messina, Ruth Geraldes, Susanna Asseyer, Hadas Stiebel-Kalish, Frederike Cosima Oertel, Vahid Shaygannejad, Mohammad Ali Sahraian, Ho Jin Kim, Jeffrey L Bennett, Chotima Böttcher, Hanna G Zimmermann, Brian G Weinshenker, Friedemann Paul, Nasrin Asgar. Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT). Frontiers in immunology. vol 15. 2024-07-18. PMID:39021565. |
comorbidities in patients with multiple sclerosis (ms) and antibody-mediated diseases of the central nervous system (cns) including neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein (mog)-antibody-associated disease (mogad) are common and may influence the course of their neurological disease. |
2024-07-18 |
2024-07-20 |
human |